Allergan plc announced the company has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA® Cohesive breast implants, offering women undergoing reconstruction, augmentation or revision

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In